Edwards Lifesciences Corporation (EW) Return on equity 2016–2025
Edwards Lifesciences Corporation (EW) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
10.4%FY2025 · since FY2016: 21.7% → 10.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 10.4% | -31.4 pp |
| FY2024 | 41.8% | +20.7 pp |
| FY2023 | 21.1% | -5.1 pp |
| FY2022 | 26.2% | +0.5 pp |
| FY2021 | 25.8% | +7.8 pp |
| FY2020 | 18.0% | -7.2 pp |
| FY2019 | 25.2% | +2.2 pp |
| FY2018 | 23.0% | +3.3 pp |
| FY2017 | 19.7% | -2.0 pp |
| FY2016 | 21.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice